Sereact has secured $110 million in Series B funding, a follow-on to its 2025 €25 million Series A. The company plans to use these funds to scale its 'Cortex 2' offering and establish its first U.S. office in Boston, aiming to hire local staff. This round was led by Headline, with participation from Bullhound Capital, Daphni, and Felix Capital, and saw continued investment from existing backers Air Street Capital, Creandum, and Point Nine.
Amount: $100.0M